Meeder Advisory Services Inc. Has $3.63 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Meeder Advisory Services Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,386 shares of the medical equipment provider’s stock after buying an additional 22 shares during the quarter. Meeder Advisory Services Inc.’s holdings in Intuitive Surgical were worth $3,629,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Mirador Capital Partners LP grew its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares in the last quarter. Advisors Asset Management Inc. lifted its holdings in shares of Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after acquiring an additional 1,129 shares during the last quarter. Consolidated Planning Corp boosted its position in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after buying an additional 76,649 shares during the period. Finally, ABLE Financial Group LLC acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $604,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares of the company’s stock, valued at $757,625. This represents a 15.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock valued at $45,897,071 over the last three months. 0.90% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Mizuho raised their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Finally, Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $529.72 on Monday. The company’s 50-day moving average is $499.29 and its 200 day moving average is $458.50. The company has a market capitalization of $188.68 billion, a P/E ratio of 84.82, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.